Table 2: Medication used in the investigated collective of diabetic patients with and without cardiovascular complications (CVCs).

Medication Patients without CVCs (n = 32) Patients with CVCs (n = 28) p*
n % n %
Metformin 24 75 19 67.9 0.05
DPP4 Inhibitors or Incretine mimetica 12 37.5 9 32.1 0.498
Sulfonylureas 4 12.5 6 21.4 0.49
Insulin 14 43.8 19 67.8 0.07
Statins 14 43.8 23 82.1 0.01
Diuretics 16 50 18 64.3 0.27
Beta Blockers 15 46.9 20 71.4 0.05
Calcium antagonists 12 37.5 9 32.1 0.49
ACE-Inhibitors or AT1-Blockers 26 81.3 26 92.8 0.26

*bold denotes p < 0.05.